40
Participants
Start Date
January 10, 2020
Primary Completion Date
October 20, 2024
Study Completion Date
November 20, 2024
Recombinant Interferon Alpha
Recombinant Interferon Alpha, with an initial dose of 300 wu twice a week. Other interferons that have been listed can be used if Recombinant Interferon Alpha (300 wu) is not available, and the specific dose will be determined by the researchers;
Pegylated interferon alfa-2b
Pegylated Interferon Alfa-2b, with an initial dose of 135 ug once a week (body surface area \< 1.73 m2) or 180 ug once a week ( body surface area≥1.73 m2).
RECRUITING
Institute of Hematology & Blood Diseases Hospital, Tianjin
Institute of Hematology & Blood Diseases Hospital, China
OTHER